Epsilon M&A Deal Report - Lab 21 Blood Bank Screening Business
Transaction Multiples for the Valuation of Private Companies
Trinity Biotech / Lab 21 Blood Bank Screening Business
No EMAT :
64992
Announced Date :
17/10/2013
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Trinity Biotech
Target :
Lab 21 Blood Bank Screening Business
Country :
United Kingdom
Sector of activity :
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Medical Diagnostic Laboratory
- Medical Equipment > Health Care Providers, Medical Equipment and Supplies > Health, Pharmaceuticals & Biotechnology > Diagnostic Medical Equipment
Business Description :
The Blood Bank Screening Business of Lab21 Ltd. comprises TPHA and ELISA products for blood bank screening . > Located in Cambridge and Newmarket in the United Kingdom, the business employs...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|||||||
| Current |
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Medical Diagnostic Laboratory » = 55
- Number of EMAT Reports / sub-sector « Diagnostic Medical Equipment » = 37
| Date | Acquirer | Target | Country | Multiples | See details |
| 12/02/2014 | Lab Top Medizinische Laboratorien | Cyto Obwegeser | Switzerland | * | 64979 |
| 02/06/2014 | Private Group led by Astorg Partners and Montagu Private Equity | Sebia | France | * | 64974 |
Source: Epsilon Research / EMAT
